• How It Works
    • History
    • How It Works
    • FAQ
    • Values
    • ESG Commitment
    • Definitions
  • Portfolio
  • Latest Articles

MEDTECH

July 31st

Oneview’s MedTech combats COVID-19 and keeps everyone safe

  Archived
Respiri Limited signs joint development agreement with Phenix Health, surges 50%

April 14th 2020

Respiri Limited signs joint development agreement with Phenix Health, surges 50%

Non-elective treatment profile provides Avita Medical with income stability

April 8th 2020

Non-elective treatment profile provides Avita Medical with income stability

Investors flock to Lifespot as a telehealth play

March 25th 2020

Investors flock to Lifespot as a telehealth play

OncoSil granted FDA Breakthrough Device Designation

March 18th 2020

OncoSil granted FDA Breakthrough Device Designation

OncoSil on verge of CE Mark approval

February 27th 2020

OncoSil on verge of CE Mark approval

HeraBEAT users could be in line for full refunds on the cost of the product

December 4th 2019

HeraBEAT users could be in line for full refunds on the cost of the product

HeraMED CEO David Groberman talks about the company’s progress

December 2nd 2019

HeraMED CEO David Groberman talks about the company’s progress

BPH ready to cash in on high profile energy investments

November 26th 2019

BPH ready to cash in on high profile energy investments

Page 1 of 3 next >

Connect with us

EXPLORE

  • Finfeed Portfolio
  • Latest Articles
  • How It Works
  • Archived Articles
  • About StocksDigital
  • News
  • PORTFOLIOS

  • Next Investors
  • Catalyst Hunter
  • Wise-Owl
  • STOCKS

    FOLLOW OUR INVESTMENT COMMENTARY & ANALYSIS
      CUSTOMER NOTICE | PRIVACY POLICY | FINANCIAL SERVICES GUIDE | DISCLOSURE POLICY  
    The information in this website is general information only. Any advice is general advice only. Your personal objectives, financial situation or needs have not been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice. S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877).
    © 2021   |   AFSL (CAR No.433913)